Base de données de recherche subventionnée canadienne sur la COVID-19

Algonquin College
Ambrose University
Association for Canadian Studies
Athabasca University
Aurora College

B.C. Centre for Disease Control
B.C. Centre for Excellence in HIV/AIDS
B.C. Children's Hospital
B.C. Women's Hospital
Bishop's University
Brandon University
British Columbia Centre on Substance Use
Brock University
Bruyère Research Institute

Dalhousie University
Dawson College
Durham College

École de technologie supérieure
École nationale d'administration publique
École Polytechnique de Montréal
Emily Carr University of Art and Design

Fanshawe College
First Nations Health Authority
Fleming College

Georgian College
Grant MacEwan University

HEC Montréal
Hospital for Sick Children
Humber College
Huron University College

Indigenous Diabetes Health Circle
INRS
Institut de recherches cliniques de Montréal
Institut de tourisme et d'hôtellerie du Québec
Institut national de la recherche scientifique
Institut national de santé publique du Québec
Institute for Work & Health
IWK Health Centre

John Abbott College
Justice Institute of British Columbia

Keenan Research Centre
King's University College at Western University
Kwantlen Polytechnic University

MacEwan University (Grant MacEwan University)
McGill University
McMaster University
Memorial University of Newfoundland
Métis Nation of Ontario
Mount Royal University
Mount Saint Vincent University
Moyo Health and Community Services

Native Women's Association of Canada
North Island College
North York General Hospital
Northern Ontario School of Medicine
Nova Scotia Health Authority

OCAD University
Ontario Centre of Excellence for Child and Youth Mental Health
Ontario Institute for Cancer Research
Ontario Tech University
Ontario Tech University (University of Ontario Institute of Technology)
Ottawa Heart Institute Research Corporation
Ottawa Hospital Research Institute

Princess Margaret Cancer Centre

Québec à Chicoutimi
Québec à Montréal
Québec à Rimouski
Québec à Trois-Rivières
Queen's University

Royal Alexandra Hospital
Royal Roads University
Ryerson University

TÉLUQ
The University of Calgary
The University of Regina
Thompson Rivers University
Toronto General Research Institute
Trent University
Trillium Health Partners

Vancouver Island University

Western University
Western University (The University of Western Ontario)
Wilfrid Laurier University
Women's College Hospital

York University
Yukon University

Back to main page

Displaying 171 through 180 of 1176 results (Download Results)

Show results per page

Palliative Care for People who use Substances During Communicable Disease Epidemics and Pandemics: A Scoping Review

Lau, Jenny | Princess Margaret Cancer Centre | Operating Grant | $49,500

CIHR Ontario 2020

Mobilizing Knowledge on the Use of Virtual Care Interventions to Provide Trauma-Focused Treatment to Individuals and Families At-Risk of Domestic Violence During COVID-19

Montesanti, Stephanie R | University of Alberta | Operating Grant | $50,000

CIHR Alberta 2020

COVID-19: Improving the Evidence to Treat an Emerging Infection Through Observational Studies and a Randomized Trial

Murthy, Srinivas | University of British Columbia | Operating Grant | $954,936

CIHR British Columbia 2020

Anti-Coronavirus Therapy (ACT) to prevent COVID‑19 disease progression: a clinical trial platform

Eikelboom, John W | McMaster University | Operating Grant | $2,937,119

CIHR Ontario 2020

Kukaa Salama (Staying Safe): A Pre-Post Trial of a WhatsApp Social Group for Increasing COVID‑19 Prevention Practices with Urban Refugee and Displaced Youth in Kampala, Uganda

Logie, Carmen | University of Toronto | Operating Grant | $295,246

CIHR Ontario 2020

The Canadian Critical Care Trials Group

Fowler, Robert A | Sunnybrook Research Institute | Operating Grant | $150,000

CIHR Ontario 2020

Sex as a Biological Variable Supplement – Drug repurposing for the rapid development and evaluation of SARS-CoV-2 antivirals

Côté, Marceline | University of Ottawa | Operating Grant | $40,000

CIHR Ontario 2020

La réorganisation des services institutionnels et communautaires auprès des personnes en situation d’itinérance et les besoins des personnes en situation d’itinérance pour faire face à la pandémie de COVID-19

Bellot, Céline | Université de Montréal | Operating Grant | $206,261

CIHR Quebec 2020

COVID-19 trilogy: ARDS, inflammation and coagulopathy.

Flamand, Louis | CHU de Québec | Operating Grant | $226,625

CIHR Quebec 2020

Development of vaccine candidates and monoclonal antibodies to interrupt the spread of the novel coronavirus, COVID-19.

Kozak, Robert A | University of Toronto | Operating Grant | $999,356

CIHR Ontario 2020

Base de données de recherche subventionnée canadienne sur la COVID-19

Advanced Keyword Search

Provinces & Territories (12)

Institutions (175)

A

B

C

D

E

F

G

H

I

J

K

L

M

N

O

P

Q

R

S

T

U

V

W

Y

Years (4)

Funding Agencies (3)

Languages (2)

Funding Amount

Palliative Care for People who use Substances During Communicable Disease Epidemics and Pandemics: A Scoping Review

Mobilizing Knowledge on the Use of Virtual Care Interventions to Provide Trauma-Focused Treatment to Individuals and Families At-Risk of Domestic Violence During COVID-19

COVID-19: Improving the Evidence to Treat an Emerging Infection Through Observational Studies and a Randomized Trial

Anti-Coronavirus Therapy (ACT) to prevent COVID‑19 disease progression: a clinical trial platform

Kukaa Salama (Staying Safe): A Pre-Post Trial of a WhatsApp Social Group for Increasing COVID‑19 Prevention Practices with Urban Refugee and Displaced Youth in Kampala, Uganda

The Canadian Critical Care Trials Group

Sex as a Biological Variable Supplement – Drug repurposing for the rapid development and evaluation of SARS-CoV-2 antivirals

La réorganisation des services institutionnels et communautaires auprès des personnes en situation d’itinérance et les besoins des personnes en situation d’itinérance pour faire face à la pandémie de COVID-19

COVID-19 trilogy: ARDS, inflammation and coagulopathy.

Development of vaccine candidates and monoclonal antibodies to interrupt the spread of the novel coronavirus, COVID-19.